Deficiencies Continue to Plague Dr. Reddy’s Facility

Drug Industry Daily
A A
The FDA has cited a Dr. Reddy’s manufacturing site for a slew of violations, including deficient air supply in aseptic processing areas and a lack of microbiological testing.

To View This Article:

Login

Subscribe To Drug Industry Daily